Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.2550 (0.31%) ($3.2550 - $3.2550) on Fri. Mar. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.89% (three month average) | RSI | 63 | Latest Price | $3.2550(0.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.3% a day on average for past five trading days. | Weekly Trend | CGEN advances 1.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) QQQ(98%) IVW(90%) SPY(90%) IWO(89%) XBI(89%) | Factors Impacting CGEN price | CGEN will decline at least -1.945% in a week (0% probabilities). VXX(-69%) UUP(-28%) TBT(-15%) UNG(-11%) TIP(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.945% (StdDev 3.89%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $3.23(0.77%) | 10 Day Moving Average | $3.16(3.01%) | 20 Day Moving Average | $3.13(3.99%) | To recent high | -29.5% | To recent low | 18.4% | Market Cap | $269m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |